DISCOUNT ZERTIFIKAT - AMGEN | Market Closed - Börse Stuttgart 15:23:27 2024-05-24 EDT | ||
| 256.7 EUR | -0.39% |
|
| Current month | +5.93% | ||
| 1 month | +6.02% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 24-05-24 | 256.7 | -0.39% |
| 24-05-23 | 257.7 | -0.31% |
| 24-05-22 | 258.5 | +0.40% |
| 24-05-21 | 257.4 | -0.12% |
| 24-05-20 | 257.7 | +0.35% |
Delayed Quote Börse Stuttgart
Last update May 24, 2024 at 03:23 pm
More quotesStatic data
| Product type | Discount Certificates |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | Morgan Stanley |
| WKN | ME680U |
| ISIN | DE000ME680U8 |
| Date issued | 2024-01-02 |
| Maturity | 2024-09-20 (117 Days) |
| Parity | 1 : 1 |
| Emission price | 238.5 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 258.5 € |
|---|---|
| Lowest since issue | 233 € |
| Spread | 0.05 € |
| Spread % | 0.02% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
305.8
USD
Average target price
316.3
USD
Spread / Average Target
+3.41%
- Stock Market
- Certificates
- Certificat
